CC Sabathia will have a New York Yankees logo on the cap of his Hall of Fame plaque and Bill Wagner will have the symbol of ...

Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase 2a trial – - Data presented at AACR 2023 supports ...

A Tahoe businessman is feeling the backlash over his Facebook comment about the children of immigrants. Parker Alexander, founder of the apparel company The Heartbeat Brand, came under criticism for ...

The supply agreement supports the evaluation of Immuneering’s lead product candidate, IMM-1-104, in combination with Libtayo in patients with unresectable or metastatic RAS-mutant non-small cell ...

The supply agreement supports the evaluation of Immuneerings' lead product candidate, IMM-1-104, in combination with Regeneron's immunotherapy drug Libtayo in patients with advanced non-small cell ...

Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase 2a trial - - Data presented at AACR 2023 supports ...

The comment was deleted not long afterward, but screenshots of it were posted on social media — as were images of defaced Heartbeat Brand hats ... the Tahoe Heartbeat logo, which combines ...

Libtayo was the sixth PD-L/PD-L1 inhibitor to reach the market, starting out as a therapy for another skin cancer called cutaneous squamous cell carcinoma (CSCC), and the rarity of that disease ...

Gov. Gavin Newsom and President Donald Trump — who have very visibly traded political fire but who also have worked together — meet at the White House on Wednesday as the California governor ...

Sanofi and Regeneron have reported new data for Libtayo that suggests the drug could be a contender. Overall survival (OS) was 22 months with the combination, compared to 13 months with chemo on ...